Compare IDYA & MSGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDYA | MSGE |
|---|---|---|
| Founded | 2015 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.0B |
| IPO Year | 2019 | 2023 |
| Metric | IDYA | MSGE |
|---|---|---|
| Price | $35.87 | $73.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 7 |
| Target Price | $52.86 | ★ $61.00 |
| AVG Volume (30 Days) | ★ 1.4M | 532.8K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.90 | N/A |
| EPS | N/A | ★ 1.59 |
| Revenue | $218,710,000.00 | ★ $942,734,000.00 |
| Revenue This Year | N/A | $10.53 |
| Revenue Next Year | $201.05 | $6.53 |
| P/E Ratio | ★ N/A | $46.33 |
| Revenue Growth | ★ 3024.43 | N/A |
| 52 Week Low | $21.33 | $35.31 |
| 52 Week High | $40.58 | $82.79 |
| Indicator | IDYA | MSGE |
|---|---|---|
| Relative Strength Index (RSI) | 50.59 | 45.24 |
| Support Level | $32.85 | $73.00 |
| Resistance Level | $38.17 | $82.79 |
| Average True Range (ATR) | 1.46 | 2.34 |
| MACD | -0.47 | -0.71 |
| Stochastic Oscillator | 5.75 | 6.69 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.